Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial

Authors :: Hochberg, Jessica
Miller, Renuka P.
Hanley, Patrick J.
McCormack, Sarah
Harrison, Lauren
Militano, Olga
Brand, Phyllis
Bollard, Catherine M.
Cairo, Mitchell S.
Source :: Biology of Blood & Marrow Transplantation. Feb2015 Supplement, Vol. 21 Issue 2, pS196-S197. 1p.
Publication Year :: 2015

Subjects :: *STEM cell transplantation
*CELLULAR therapy
*IMMUNOTHERAPY
*MEMBRANE proteins
*EPSTEIN-Barr virus
*HODGKIN'S disease treatment
*CANCER relapse
*CYTOTOXIC T cells

Full Text Access

Tools